Hjem › Kreft i gallesystemet
Kliniske studier for Kreft i gallesystemet rekrutterer i USA
40 studier for Kreft i gallesystemet rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX18 studier
- Los Angeles, CA11 studier
- Boston, MA11 studier
- New York City, NY10 studier
- Nashville, TN9 studier
- San Antonio, TX8 studier
- Baltimore, MD8 studier
- Washington, DC7 studier
- Arlington, VA7 studier
- Pittsburgh, PA7 studier
- Baldwin Park, CA6 studier
- Cleveland, OH6 studier
- Dallas, TX6 studier
- Columbus, OH6 studier
- Madison, WI6 studier
- Philadelphia, PA6 studier
- Detroit, MI5 studier
- Louisville, KY5 studier
- Tampa, FL5 studier
- Miami, FL5 studier
- Orange, CA4 studier
- Seattle, WA4 studier
- Aurora, CO4 studier
- Queens, NY4 studier
- Orlando, FL4 studier
- Buffalo, NY3 studier
- Edison, NJ3 studier
- Santa Monica, CA3 studier
- Salt Lake City, UT3 studier
- St. Louis, MO3 studier
- San Diego, CA3 studier
- Grand Rapids, MI3 studier
- Chicago, IL3 studier
- Tucson, AZ3 studier
- Providence, RI3 studier
- Denver, CO3 studier
- Portland, OR3 studier
- Birmingham, AL3 studier
Etter delstat
- Alabama3 studier
- Arizona4 studier
- California20 studier
- Colorado7 studier
- Connecticut3 studier
- District of Columbia4 studier
- Florida14 studier
- Georgia4 studier
- Illinois5 studier
- Kentucky6 studier
- Maryland11 studier
- Massachusetts11 studier
- Michigan9 studier
- Minnesota5 studier
- Missouri4 studier
- New Jersey5 studier
- New York15 studier
- Ohio10 studier
- Oregon3 studier
- Pennsylvania10 studier
- Rhode Island3 studier
- Tennessee10 studier
- Texas23 studier
- Utah4 studier
- Virginia9 studier
- Washington5 studier
- Wisconsin6 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RekruttererObservasjonsstudie
Alder 2 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01950572A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06219941A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07265674Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05482893A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06428409Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RekruttererFase 2
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05489211Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
RekruttererFase 2
Alder 19 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07146646Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06282575SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07812805Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06293898CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06548412AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruttererFase 1/2
Alder 18 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07038343Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06084481Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 99 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05517811A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT06774963Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
RekruttererFase 3
Alder 18 til 99 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT06467357A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06330064D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT06622057A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06101277A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07458347Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.